These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 10840757)

  • 1. Glycosaminoglycan binding assays.
    Hoogewerf AJ; Kuschert GS
    Methods Mol Biol; 2000; 138():173-7. PubMed ID: 10840757
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiolabeled chemokine binding assays.
    Daugherty BL; Siciliano SJ; Springer MS
    Methods Mol Biol; 2000; 138():129-34. PubMed ID: 10840750
    [No Abstract]   [Full Text] [Related]  

  • 3. Solid-phase binding assay to study interaction of chemokines with glycosaminoglycans.
    Kuschert GS; Hubbard RE; Power CA; Wells TN; Hoogewerf AJ
    Methods Enzymol; 1997; 287():369-78. PubMed ID: 9330333
    [No Abstract]   [Full Text] [Related]  

  • 4. Radioligand binding assays and quantitative autoradiography of endothelin receptors.
    Davenport AP; Kuc RE
    Methods Mol Biol; 2002; 206():45-70. PubMed ID: 12152234
    [No Abstract]   [Full Text] [Related]  

  • 5. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines.
    Proudfoot AE; Handel TM; Johnson Z; Lau EK; LiWang P; Clark-Lewis I; Borlat F; Wells TN; Kosco-Vilbois MH
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1885-90. PubMed ID: 12571364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma 11-hydroxycorticoids by a fluorimetric method and a competitive protein-binding assay kit.
    McBride J; Gilmore A
    Med Lab Sci; 1977 Oct; 34(4):331-5. PubMed ID: 600037
    [No Abstract]   [Full Text] [Related]  

  • 7. Radioligand binding studies. Pharmacological profiles of cloned Y-receptor subtypes.
    McCrea KE; Herzog H
    Methods Mol Biol; 2000; 153():231-9. PubMed ID: 10957997
    [No Abstract]   [Full Text] [Related]  

  • 8. Unknown radioligand specific activity.
    Wiener HL; Reith ME
    Trends Pharmacol Sci; 1993 Aug; 14(8):294-6. PubMed ID: 8305068
    [No Abstract]   [Full Text] [Related]  

  • 9. Chapter 13. Characterizing proteolytic processing of chemokines by mass spectrometry, biochemistry, neo-epitope antibodies and functional assays.
    Starr AE; Overall CM
    Methods Enzymol; 2009; 461():281-307. PubMed ID: 19480924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioligand-binding methods for membrane preparations and intact cells.
    Bylund DB; Deupree JD; Toews ML
    Methods Mol Biol; 2004; 259():1-28. PubMed ID: 15250483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent advances in competitive radioassay and enzyme immunoassay (author's transl)].
    Irie M; Tsuji A
    Rinsho Hoshasen; 1978 Mar; 23(3):337-45. PubMed ID: 344948
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification and characterization of pseudoirreversible nonpeptide antagonists of the neuropeptide Y Y5 receptor and development of a novel Y5-selective radioligand.
    Mullins D; Adham N; Hesk D; Wu Y; Kelly J; Huang Y; Guzzi M; Zhang X; McCombie S; Stamford A; Parker E
    Eur J Pharmacol; 2008 Dec; 601(1-3):1-7. PubMed ID: 18976648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of allosteric interactions using radioligand-binding techniques.
    Lazareno S
    Methods Mol Biol; 2004; 259():29-46. PubMed ID: 15250484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Configuring radioligand receptor binding assays for HTS using scintillation proximity assay technology.
    Carpenter JW; Laethem C; Hubbard FR; Eckols TK; Baez M; McClure D; Nelson DL; Johnston PA
    Methods Mol Biol; 2002; 190():31-49. PubMed ID: 12029825
    [No Abstract]   [Full Text] [Related]  

  • 15. [Establishment of a new method for insulin antibody measurement by antibody beads].
    Sato M; Hashimoto F; Ooboshi C; Hirota M; Oshima I; Shima K
    Rinsho Byori; 1987 May; 35(5):582-6. PubMed ID: 3613169
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological profile of radioligand binding to the norepinephrine transporter: instances of poor indication of functional activity.
    Reith ME; Wang LC; Dutta AK
    J Neurosci Methods; 2005 Apr; 143(1):87-94. PubMed ID: 15763140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive binding assays for biotin-binding proteins.
    White HB
    Methods Enzymol; 1997; 279():464-6. PubMed ID: 9211298
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of chemokine receptor endocytosis and recycling.
    Signoret N; Marsh M
    Methods Mol Biol; 2000; 138():197-207. PubMed ID: 10840760
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationships between glycosaminoglycan and receptor binding sites in chemokines-the CXCL12 example.
    Laguri C; Arenzana-Seisdedos F; Lortat-Jacob H
    Carbohydr Res; 2008 Aug; 343(12):2018-23. PubMed ID: 18334249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different stereochemical requirements for CXCR4 binding and signaling functions as revealed by an anti-HIV, D-amino acid-containing SMM-chemokine ligand.
    Dong CZ; Kumar S; Choi WT; Madani N; Tian S; An J; Sodroski JG; Huang Z
    J Med Chem; 2005 Dec; 48(25):7923-4. PubMed ID: 16335916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.